This announcement concerns the meeting schedule for the Shenzhen Stock Exchange's review of Guangzhou Medprin Regenerative Medical Technology Co., Ltd.'s proposed acquisition of 100% equity in Guangzhou Medi-Ait Medical Technology Co., Ltd. The transaction involves issuing shares and paying cash, along with raising supporting funds. The final implementation is subject to SZSE review and CSRC registration.
Summary generated by AI · Always verify with source document
Guangzhou Medprin Regenerative Medical Technology Co., Ltd.
Announcement on the Meeting Arrangement for Shenzhen Stock Exchange's Review of the Company's Issuance of Shares and Payment of Cash to Acquire Assets, Raising of Supporting Funds, and Related Party Transaction Matters
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosure, and there are no false records, misleading statements, or significant omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.